Citigroup Upgrades Puxin (NYSE:NEW) to “Buy”

Share on StockTwits

Puxin (NYSE:NEW) was upgraded by equities researchers at Citigroup from a “neutral” rating to a “buy” rating in a research report issued on Monday, The Fly reports.

Separately, ValuEngine downgraded shares of Puxin from a “sell” rating to a “strong sell” rating in a report on Wednesday, October 30th.

Shares of NEW stock traded down $0.24 during mid-day trading on Monday, hitting $10.64. 431,913 shares of the stock traded hands, compared to its average volume of 191,996. The company has a debt-to-equity ratio of 1.65, a quick ratio of 0.37 and a current ratio of 0.37. The stock’s fifty day moving average is $8.87 and its two-hundred day moving average is $7.30. Puxin has a 52-week low of $5.00 and a 52-week high of $14.04.

A number of large investors have recently modified their holdings of the stock. Resources Investment Advisors LLC. acquired a new stake in shares of Puxin during the 2nd quarter worth approximately $276,000. Citadel Advisors LLC acquired a new stake in shares of Puxin during the 2nd quarter worth approximately $332,000. Jane Street Group LLC acquired a new stake in shares of Puxin during the 2nd quarter worth approximately $622,000. Finally, Ward Ferry Management BVI Ltd grew its stake in shares of Puxin by 62.1% during the 2nd quarter. Ward Ferry Management BVI Ltd now owns 2,439,638 shares of the company’s stock worth $15,321,000 after purchasing an additional 934,600 shares during the period. Institutional investors own 9.32% of the company’s stock.

Puxin Company Profile

Puxin Limited, through its subsidiaries, provides after-school education services in China. It offers a range of K-12 and study-abroad tutoring programs designed to help students prepare for admission tests and applications for top schools, universities, and graduate programs in China and other countries.

Featured Article: What is the G-20?

The Fly

Receive News & Ratings for Puxin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puxin and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.